Lyell Immunopharma Inc (LYEL) institutional holders · rev $36.0K
Lyell Immunopharma Inc institutional holders from SEC Form 13F, top 4 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| CITADEL ADVISORS LLC | 381,462 | $7.7M | 2026-03-31Prior quarter |
| STATE STREET CORP | 185,322 | $2.6M | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 114,491 | $2.3M | 2026-03-31Prior quarter |
| FMR LLC | 2,151 | $30.2K | 2026-06-30 |
LYEL institutional holders FAQ
How many LYEL 13F holders are listed on this page?
This page lists 2 cached Lyell Immunopharma Inc (LYEL) 13F holders. Holders: https://lician.com/institutional/lyel
Who is the largest LYEL 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/lyel/93751. Holders: https://lician.com/institutional/lyel
What value and shares did the largest LYEL 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 185,322 shares and a value of $2.6M.
What is the latest LYEL 13F report date on this page?
The latest cached 13F report date on this Lyell Immunopharma Inc (LYEL) holders table is Jun 30, 2026.
Which LYEL 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Lyell Immunopharma Inc (LYEL) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/lyel
Where are LYEL institutional holders listed?
Cached 13F holders for Lyell Immunopharma Inc (LYEL) are listed at https://lician.com/institutional/lyel. Filer directory: https://lician.com/holders
What is LYEL's latest revenue?
Latest cached Lyell Immunopharma Inc (LYEL) revenue for Dec 31, 2025 was $36.0K. Statements: https://lician.com/financials/lyel
Not investment advice. Figures as filed or reported, not a live feed.